Xiao-Ya Feng

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Neovibsanins are believed to be promising candidates for the development of novel therapeutic agents to treat neurological diseases like Alzheimer's disease. It has been shown that chronic cerebral hypoperfusion is linked to neurodegenerative disorders and their subsequent cognitive impairment. In the present study effect of neovibsanin B (NVB) on spatial(More)
  • 1